Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Sponsors
Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients with a clinical diagnosis of stable COPD (GOLD stage 1-2); consistent with TCM lung qi deficiency syndrome; 2. No history of respiratory tract infection or acute exacerbation in the 4 weeks prior to randomization; 3. Those who are able to successfully perform pulmonary function measurements; 4. Patients are informed and sign written consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with chronic lung diseases in which intervention or treatment is required, such as interstitial lung diseasebronchial asthma, active tuberculosis, or bronchiectasis; 2. Patients with a combination of severe primary diseases, such as cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic system diseases, endocrine diseases, severe mental disorders, malignant tumors; 3. Patients have evidence of alcohol or drug abuse, known or suspected allergy to the study drug or some of its components, and currently uses oral corticosteroids regularly; 4. Women who are breast-feeding, pregnant or expecting a child; 5. Patients who have been involved in any other clinical study in the past 6 months; 6. Patients unable to successfully use a DPI or perform pulmonary function measurements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lung function; | — |
Secondary
| Measure | Time frame |
|---|---|
| St George's Respiratory Questionnaire;COPD acute exacerbations;COPD assessment test;modified British medical research council; | — |
Countries
China
Contacts
Public ContactXiaohong Xie
Department of Respiratory Medicine, Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed